Altered anandamide degradation in attention-deficit/hyperactivity disorder

Neurology. 2009 Apr 28;72(17):1526-7. doi: 10.1212/WNL.0b013e3181a2e8f6.
No abstract available

MeSH terms

  • Adolescent
  • Amidohydrolases / analysis
  • Amidohydrolases / blood
  • Arachidonic Acids / analysis
  • Arachidonic Acids / metabolism*
  • Attention Deficit Disorder with Hyperactivity / blood
  • Attention Deficit Disorder with Hyperactivity / enzymology*
  • Attention Deficit Disorder with Hyperactivity / physiopathology
  • Brain / enzymology*
  • Brain / physiopathology
  • Cannabinoid Receptor Modulators / analysis
  • Cannabinoid Receptor Modulators / metabolism*
  • Child
  • Cohort Studies
  • Dopamine / metabolism*
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Down-Regulation / physiology
  • Endocannabinoids
  • Humans
  • Lymphocytes / metabolism
  • Male
  • Neural Pathways / metabolism
  • Neural Pathways / physiopathology
  • Phospholipase D / analysis
  • Phospholipase D / blood
  • Polyunsaturated Alkamides / analysis
  • Polyunsaturated Alkamides / metabolism*
  • Predictive Value of Tests

Substances

  • Arachidonic Acids
  • Cannabinoid Receptor Modulators
  • Dopamine Plasma Membrane Transport Proteins
  • Endocannabinoids
  • Polyunsaturated Alkamides
  • Phospholipase D
  • Amidohydrolases
  • fatty-acid amide hydrolase
  • anandamide
  • Dopamine